Related Experiment Video
Updated: May 12, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Reduced Sensitivity to Negative Feedback May Lead to Risky Decision-Making in Amphetamine Users
Yu-Hua Liu1, Chiao-Yun Chen1, Neil G Muggleton2,3
1Department of Criminology, National Chung Cheng University, Chiayi, Taiwan.
None:
In Taiwan, amphetamines are the main drug of abuse. While drug abuse is often related to individual risky decision-making, how this relates to underlying neural mechanisms in amphetamine abusers remains unclear. The current study was carried out to help better understand this. A Balloon Analogue Risk Task (BART) was used to examine individual risky decision-making in conjunction with event-related potential (ERP) recording and presentation of questionnaires relating to behavioural control. Compared with healthy controls, amphetamine users had a lower score on the Behavioural Inhibition System (BIS) scale and showed reduced amplitudes in feedback-related negativity (FRN) and error-related negativity (ERN) ERP components following negative feedback on the task. Amphetamine users were less sensitive to punitive or aversive stimuli. This reduced sensitivity might lead to a higher tendency for risky decision-making, with them less able to learn from mistakes and thus repeatedly engage in risky behaviours.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drug Abuse and Addiction: Pharmacological Phenomena
Desensitization and Tachyphylaxis
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

